eAccess Technology in Specialty Pharmacy

Gregory R. Morris, chief commercial officer at VirMedica, discusses how eAccess can benefit patients and providers.

Related Content:

InterviewsSpecialty Pharmacy

Daily Medication Pearl: Kovaltry (Antihemophilic Factor)

Pembrolizumab Plus Lenvatinib Show Promise in Advanced Endometrial Carcinoma

Durvalumab Plus Chemotherapy Reduced Risk of Death by 20% in First-Line Advanced Biliary Tract Cancer